# Safety and Efficacy of SH T00660AA in Treatment of Endometriosis

> **NCT00225186** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 168 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Visanne (SH T00660AA , BAY86-5258)

## Key facts

- **NCT ID:** NCT00225186
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2014-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00225186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00225186, "Safety and Efficacy of SH T00660AA in Treatment of Endometriosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00225186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*